Technology, Healthcare Feb 10, 2022 06:00 PM (GMT+8) · EqualOcean
In order to meet the rapidly growing business demand, Chongqing Boteng Pharmaceutical Technology Co., Ltd. today announced an investment of 260 million yuan to expand the API cdmo capacity located in Chongqing Changshou production base. The expansion project is workshop 301 of Changshou production base, which is positioned as a medium-sized commercial GMP intermediate flexible production capacity. The project is expected to be put into operation in March 2023. After the project is put into operation, the total capacity of Changshou production base will be 900m ³ Increase the production capacity by 16%.